Ibandronate Sodium

Drug Usage Statistics, United States, 2004 - 2014

Number of Prescriptions Over Time (2004 - 2014)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2005 490 -
2006 181  309
2007 153  28
2008 148  5
2009 170  22
Year Rank Change
2010 158  12
2011 232  74
2012 269  37
2013 300  31
2014 287  13

Patient Out-Of-Pocket Cost Over Time (2004 - 2014)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2014)
Alendronate Sodium 8,459,285
Risedronate 1,557,898
Ibandronate Sodium (this drug) 1,498,979

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Boniva
Generic Drug Synonyms and Salts
  • Ibandronate Sodium

FDA Approval Information

Established Pharmacologic Class (EPC): Bisphosphonate
Initial FDA approval date: 5/16/2003
First FDA applicant: Hoffmann La Roche Inc
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2004-2014. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 17.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

Easily learn drug therapy with our high-yield videos. The Top 250 Drugs by ClinCalc Academy
©2017 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Mar 4, 2017
Back to Top
Top